| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Investigations |
Departments of Radiology, Chemistry, Surgery, Pediatrics, and Radiation Safety, Duke University Medical Center, Durham, North Carolina
Elevated levels of choline (trimethyl-2-hydroxyethylammonium) and choline kinase (CK) activity in neoplasms have motivated the development of positron-labeled choline analogs for noninvasive detection of cancer using PET. The aim of this study was to further evaluate [18F]fluorocholine (fluoromethyl-dimethyl-2-hydroxyethylammonium [FCH]) as an oncologic probe in comparison with several other closely related molecules. Methods: FCH, [18F]fluoromethyl-methylethyl-2-hydroxyethylammonium (FMEC), [18F]fluoroethyl-dimethyl-2-hydroxyethylammonium (FEC), and [18F]fluoropropyl-dimethyl-2-hydroxyethylammonium (FPC) were synthesized through [18F]fluoroalkylation reactions. In vitro phosphorylation rates of the 18F-labeled choline analogs and [methyl-14C]choline (CH) were studied using yeast CK. Several choline radiotracers were also evaluated in cultured PC-3 human prostate cancer cells. Data on chemical stability, radiation dosimetry, and toxicity of FCH were obtained. PET studies with FCH were performed on a patient with prostate cancer and a patient with a brain tumor. Results: FCH and FMEC revealed in vitro phosphorylation by CK that was similar to that of choline, whereas rates of phosphorylation of FEC and FPC were 30% (P < 0.01) and 60% (P < 0.01) lower, respectively. Accumulations of FCH, CH, and FPC in cultured PC-3 cancer cells were comparable, whereas uptake of FEC was approximately one fifth that of FCH. Dosimetry estimates using FCH biodistribution data in mice indicated that the kidneys are radiation-dose-critical organs for FCH. PET images of a patient with recurrent prostate cancer showed uptake of FCH in the prostatic bed and in metastases to lymph nodes. FCH PET showed uptake in malignancies in a patient with metastatic breast cancer. PET revealed FCH uptake in biopsy-proven recurrent brain tumor with little confounding uptake by normal brain tissues. Conclusion: The fluoromethyl choline analog FCH may serve as a probe of choline uptake and phosphorylation in cancer cells, whereas fluoroethyl (FEC) and fluoropropyl (FPC) analogs appear to have relatively poorer biologic compatibility. Preliminary PET studies on patients with prostate cancer and with breast cancer and brain tumor support further studies to evaluate the usefulness of FCH as an oncologic probe.
Key Words: choline • PET • prostate cancer • breast cancer • brain tumors
This article has been cited by other articles:
|
|
 |
|
  C. Plathow and W. A. Weber Tumor Cell Metabolism Imaging J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Kwee, J. P. Ko, C. S. Jiang, M. R. Watters, and M. N. Coel Solitary Brain Lesions Enhancing at MR Imaging: Evaluation with Fluorine 18 Fluorocholine PET Radiology, August 1, 2007; 244(2): 557 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Wyss, N. Spaeth, G. Biollaz, J. Pahnke, P. Alessi, E. Trachsel, V. Treyer, B. Weber, D. Neri, and A. Buck Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 Gliomas and Correlation with 131I-SIP(L19), a Marker of Angiogenesis J. Nucl. Med., April 1, 2007; 48(4): 608 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Ponde, C. S. Dence, N. Oyama, J. Kim, Y.-C. Tai, R. Laforest, B. A. Siegel, and M. J. Welch 18F-Fluoroacetate: A Potential Acetate Analog for Prostate Tumor Imaging--In Vivo Evaluation of 18F-Fluoroacetate Versus 11C-Acetate J. Nucl. Med., March 1, 2007; 48(3): 420 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Kwee, H. Wei, I. Sesterhenn, D. Yun, and M. N. Coel Localization of Primary Prostate Cancer with Dual-Phase 18F-Fluorocholine PET J. Nucl. Med., February 1, 2006; 47(2): 262 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-G. Choi, V. Kurnov, M. C. Kersting, A. Sreenivas, and G. M. Carman Phosphorylation of the Yeast Choline Kinase by Protein Kinase C: IDENTIFICATION OF Ser25 AND Ser30 AS MAJOR SITES OF PHOSPHORYLATION J. Biol. Chem., July 15, 2005; 280(28): 26105 - 26112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Borgwardt, L. Hojgaard, H. Carstensen, H. Laursen, M. Nowak, C. Thomsen, and K. Schmiegelow Increased Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose (FDG) Uptake in Childhood CNS Tumors Is Correlated With Malignancy Grade: A Study With FDG Positron Emission Tomography/Magnetic Resonance Imaging Coregistration and Image Fusion J. Clin. Oncol., May 1, 2005; 23(13): 3030 - 3037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Schmid, H. John, R. Zweifel, T. Cservenyak, G. Westera, G. W. Goerres, G. K. von Schulthess, and T. F. Hany Fluorocholine PET/CT in Patients with Prostate Cancer: Initial Experience Radiology, May 1, 2005; 235(2): 623 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Robinson, M. Doss, C. Shaller, D. Narayanan, J. D. Marks, L. P. Adler, D. E. Gonzalez Trotter, and G. P. Adams Quantitative Immuno-Positron Emission Tomography Imaging of HER2-Positive Tumor Xenografts with an Iodine-124 Labeled Anti-HER2 Diabody Cancer Res., February 15, 2005; 65(4): 1471 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Spaeth, M. T. Wyss, B. Weber, S. Scheidegger, A. Lutz, J. Verwey, I. Radovanovic, J. Pahnke, D. Wild, G. Westera, et al. Uptake of 18F-Fluorocholine, 18F-Fluoroethyl-L-Tyrosine, and 18F-FDG in Acute Cerebral Radiation Injury in the Rat: Implications for Separation of Radiation Necrosis from Tumor Recurrence J. Nucl. Med., November 1, 2004; 45(11): 1931 - 1938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Chen, R. Park, Y. Hou, M. Tohme, A. H. Shahinian, J. R. Bading, and P. S. Conti microPET and Autoradiographic Imaging of GRP Receptor Expression with 64Cu-DOTA-[Lys3]Bombesin in Human Prostate Adenocarcinoma Xenografts J. Nucl. Med., August 1, 2004; 45(8): 1390 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Schettino, E. L. Kramer, M. E. Noz, S. Taneja, P. Padmanabhan, and H. Lepor Impact of Fusion of Indium-111 Capromab Pendetide Volume Data Sets with Those from MRI or CT in Patients with Recurrent Prostate Cancer Am. J. Roentgenol., August 1, 2004; 183(2): 519 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Rohren, T. G. Turkington, and R. E. Coleman Clinical Applications of PET in Oncology Radiology, May 1, 2004; 231(2): 305 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G J R Cook Oncological molecular imaging: nuclear medicine techniques Br. J. Radiol., December 1, 2003; 76(suppl_2): S152 - S158. [Full Text] [PDF]
|
|
|
|
|
|
A. Dimitrakopoulou-Strauss and L. G. Strauss PET Imaging of Prostate Cancer with 11C-Acetate J. Nucl. Med., April 1, 2003; 44(4): 556 - 558. [Full Text] [PDF]
|
|
|
|
|
|
Y. Yu, A. Sreenivas, D. B. Ostrander, and G. M. Carman Phosphorylation of Saccharomyces cerevisiae Choline Kinase on Ser30 and Ser85 by Protein Kinase A Regulates Phosphatidylcholine Synthesis by the CDP-choline Pathway J. Biol. Chem., September 13, 2002; 277(38): 34978 - 34986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. DeGrado, R. E. Reiman, D. T. Price, S. Wang, and R. E. Coleman Pharmacokinetics and Radiation Dosimetry of 18F-Fluorocholine J. Nucl. Med., January 1, 2002; 43(1): 92 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hara 18F-Fluorocholine: A New Oncologic PET Tracer J. Nucl. Med., December 1, 2001; 42(12): 1815 - 1817. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
